|  |  | Research News Archive for January - March 2002 |
 | GENE OFFERS NEW CANCER CLUE |
| |  | | UK scientists have uncovered a genetic mistake associated with the most common form of leukaemia in the western world, a discovery that could significantly advance efforts to combat this disease. | | Release date: 27th March 2002 |  |
|
| SCIENTISTS CLOSE IN ON GENETIC HOTSPOTS |
| |  | | Doctors from the University of Dundee have today been awarded a grant of £37,000 from the Leukaemia Research Fund (LRF) to push forward with their pioneering research. Their studies will shed further light on the causes of acute myeloid leukaemia (AML), a cancer diagnosed in 1,600 people in the UK each year, and also help to improve its treatment. | | Release date: 28th February 2002 | |
|
| £100,000 CASH BOOST TO CANCER RESEARCH IN LEICESTER |
| |  | | Why do some cancer patients go on to develop leukaemia after receiving certain types of treatment? This is the question that researchers at the University of Leicester are looking to answer after receiving a grant of £100,000 from the UK's leading blood cancer charity, Leukaemia Research Fund (LRF). | | Release date: 19th February 2002 | |
|
| BREAKING THE VICIOUS CANCER CIRCLE |
| |  | | British scientists have discovered crucial details about the way a cancer called myeloma causes destruction of bone and painful bone fractures in patients with this disease. The Leukaemia Research Fund scientists from Oxford believe they have identified a protein called Rank ligand (RL) which sabotages the molecules controlling bone regeneration. | | Release date: 12th February 2002 | |
|
| £900,000 CASH BOOST TO CANCER RESEARCH IN OXFORD |
| |  | | The UK's leading blood cancer charity, Leukaemia Research Fund (LRF), is investing £900,000 to create a major new research programme at the Nuffield Orthopaedic Centre in Oxford. The award ensures that scientists from the University of Oxford will be leading a major research initiative in to a cancer called myeloma, which affects 3,000 people in Britain each year. | | Release date: 12th February 2002 | |
|
| FISHING FOR CRITICAL CANCER GENES |
| |  | | To unravel the mysteries of human cells, scientists often turn to the most unusual places. A young haematologist from Ashtead near Sutton is studying tiny tropical fish (Zebra fish) in order to identify which genes may cause the most common form of human leukaemia, chronic lymphocytic leukaemia (CLL). | | Release date: 24th January 2002 | |
|
| CANTERBURY SCIENTISTS SEAR FOR NEW LEUKAEMIA TREATMENT |
| |  | | A potent radioisotope with the ability to kill cancer cells is coming under investigation in Canterbury as a potential new treatment for acute myeloid leukaemia (AML). | | Release date: 22nd January 2002 | |
|
| NEWCASTLE SCIENTIST WINS PRESTIGIOUS RESEARCH AWARD |
| |  | | Dr Matthew Collin, a young haematologist from Jesmond in Newcastle, has become one of the first people to win a prestigious new research award from the UK's leading blood cancer charity Leukaemia Research Fund (LRF). The LRF Clinician Scientist Award will enable him to carry out pioneering research into bone marrow transplantation (BMT). | | Release date: 15th January 2002 | |
|
| SCIENTISTS TEST LEUKAEMIA DRUG |
| |  | | Researchers at the Royal Free Hospital and University College London Hospitals in London are examining whether the much-hailed leukaemia drug Glivec can also be used to treat a different form of this life-threatening disease. | | Release date: 14th January 2002 | |
|
|
|
| |
|
